Hims Launches Compounded Prescription Chewables, Hard Mints
Grace Mahas — May 31, 2023 — Lifestyle
References: businesswire
Hims & Hers Health Inc., the trusted consumer-first platform focused on providing personalized health and wellness experiences to consumers, announced the launch of Hard Mints by Hims, a highly personalized treatment for patients experiencing symptoms of erectile dysfunction.
The compounded chewable, wintergreen-flavored tablets are available by prescription in a range of dosages, designed to provide more options in finding the best outcomes for patients. The active ingredients of the prescription variations include vardenafil, tadalafil, and a combination of tadalafil and sildenafil, which has the same active ingredients as Cialis, Viagra, and Levitra.
Hard Mints by Hims costs $30 per month and can tailored to each individual's health needs and preferences by their medical provider. The launch of this innovative offering demonstrates the company's commitment to delivering highly personalized health solutions and the momentum gained through prescription product innovation.
The compounded chewable, wintergreen-flavored tablets are available by prescription in a range of dosages, designed to provide more options in finding the best outcomes for patients. The active ingredients of the prescription variations include vardenafil, tadalafil, and a combination of tadalafil and sildenafil, which has the same active ingredients as Cialis, Viagra, and Levitra.
Hard Mints by Hims costs $30 per month and can tailored to each individual's health needs and preferences by their medical provider. The launch of this innovative offering demonstrates the company's commitment to delivering highly personalized health solutions and the momentum gained through prescription product innovation.
Trend Themes
1. Personalized Erectile Dysfunction Treatment - Hims introduces Hard Mints, a compounded chewable treatment for erectile dysfunction available in a range of dosages tailored to each individual's health needs and preferences with a combination of active ingredients.
2. Innovative Prescription Chewables - Hims launches a highly personalized wintergreen-flavored chewable tablet for erectile dysfunction treatment, representing a new category of compounded pharmaceuticals with more options to find better outcomes for patients.
3. Consumer-first Health Platforms - Hims & Hers Health continues its commitment to personalized health and wellness experiences through the launch of Hard Mints, a demonstration of how technology-first platforms can enhance patient care and treatment options.
Industry Implications
1. Pharmaceuticals - Pharmaceutical companies can explore more innovative ways to produce and deliver chewable compounded drugs that cater to specific patient needs and preferences for a more personalized health care experience.
2. Personalized Medicine - Personalized medicine and precision health care providers can leverage Hims' example of a consumer-first platform that delivers innovative and tailored solutions for patients with unique treatment plans, including those with erectile dysfunction.
3. Telehealth - The telehealth industry can take advantage of Hims' and Hers' momentum and approach in offering highly personalized solutions and elevated experiences to wider audiences who need accessibility to convenient, affordable, and quality health care services, such as those with erectile dysfunction.
7.2
Score
Popularity
Activity
Freshness
